Procter & Gamble (NYSE:PG – Get Free Report) had its price objective cut by research analysts at Piper Sandler from $150.00 to $142.00 in a research note issued to investors on Wednesday, Marketbeat reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s target price indicates a potential downside of 3.20% from the stock’s current price.
A number of other brokerages have also issued reports on PG. Deutsche Bank Aktiengesellschaft dropped their price target on shares of Procter & Gamble from $171.00 to $162.00 and set a “hold” rating on the stock in a research note on Monday, March 30th. Barclays set a $155.00 price target on shares of Procter & Gamble in a research note on Friday, January 16th. Wells Fargo & Company dropped their price target on shares of Procter & Gamble from $177.00 to $158.00 and set an “overweight” rating on the stock in a research note on Wednesday. BNP Paribas Exane dropped their price target on shares of Procter & Gamble from $172.00 to $164.00 and set an “outperform” rating on the stock in a research note on Friday, January 16th. Finally, Dbs Bank upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating in a research note on Friday, January 23rd. Twelve investment analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus target price of $164.26.
Get Our Latest Report on Procter & Gamble
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its quarterly earnings results on Friday, January 23rd. The company reported $1.88 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.86 by $0.02. Procter & Gamble had a net margin of 19.30% and a return on equity of 32.21%. The business had revenue of $22.21 billion for the quarter, compared to analyst estimates of $22.36 billion. During the same period in the previous year, the business posted $1.88 earnings per share. The business’s revenue was up 1.5% compared to the same quarter last year. On average, analysts predict that Procter & Gamble will post 6.91 EPS for the current year.
Insider Activity at Procter & Gamble
In other Procter & Gamble news, insider Balaji Purushothaman sold 12,827 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $160.31, for a total transaction of $2,056,296.37. Following the transaction, the insider directly owned 12,639 shares in the company, valued at approximately $2,026,158.09. This represents a 50.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Moses Victor Javier Aguilar sold 15,169 shares of the company’s stock in a transaction dated Friday, February 13th. The stock was sold at an average price of $162.28, for a total transaction of $2,461,625.32. Following the transaction, the insider owned 44,735 shares in the company, valued at $7,259,595.80. The trade was a 25.32% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 348,618 shares of company stock valued at $55,462,643 in the last ninety days. Company insiders own 0.20% of the company’s stock.
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Halbert Hargrove Global Advisors LLC acquired a new stake in shares of Procter & Gamble in the third quarter valued at approximately $25,000. E Fund Management Hong Kong Co. Ltd. grew its position in shares of Procter & Gamble by 1,000.0% in the fourth quarter. E Fund Management Hong Kong Co. Ltd. now owns 165 shares of the company’s stock valued at $25,000 after purchasing an additional 150 shares during the last quarter. Litman Gregory Wealth Management LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at approximately $26,000. Park Square Financial Group LLC grew its position in shares of Procter & Gamble by 65.1% in the fourth quarter. Park Square Financial Group LLC now owns 180 shares of the company’s stock valued at $26,000 after purchasing an additional 71 shares during the last quarter. Finally, Evolution Wealth Management Inc. grew its position in shares of Procter & Gamble by 1,315.4% in the fourth quarter. Evolution Wealth Management Inc. now owns 184 shares of the company’s stock valued at $26,000 after purchasing an additional 171 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
More Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: New product push — P&G launched “Mr. Clean PRO,” a professional cleaning portfolio aimed at commercial customers; this expands addressable markets and can boost revenue durability in cleaning categories. P&G PRO Introduces Mr. Clean PRO
- Positive Sentiment: Brand relevance move — P&G struck a multi‑year, multi‑brand partnership with the WNBA to drive consumer engagement and younger/female audiences, which can support organic growth and marketing ROI. P&G WNBA Partnership Aims To Build Brand Relevance And Investor Interest
- Positive Sentiment: Positive media/strategy coverage — CNBC and other outlets highlighted P&G’s innovation strategy (what management calls its “lifeblood”), which can improve investor sentiment if investors see execution. The strategy P&G calls its ‘lifeblood’ and why it’s key to the stock’s turnaround
- Neutral Sentiment: Management succession in health care — P&G named a new health‑care CEO as a long‑time division leader retires; routine leadership changes can be neutral if transitions are smooth. P&G names new health care CEO as 33-year veteran retires
- Neutral Sentiment: Market commentary — Several outlets noted recent intraday moves (both gains and dips) and index tracking interest (Russell 1000), reflecting higher attention but not new fundamental data. Russell 1000 Index: Tracks Procter Gamble (NYSE:PG) Market Action Closely
- Negative Sentiment: Goldman Sachs trimmed its price target to $155 and kept a neutral rating — reduces upside in analyst consensus and likely weighs on near‑term sentiment. Goldman Sachs Adjusts PT on Procter & Gamble to $155
- Negative Sentiment: Multiple banks lowered targets — RBC cut its PT to $167 (keeps outperform), UBS cut to $166, Piper Sandler lowered to $142 (neutral), and Wells Fargo cut to $158 (still overweight). Collectively these trims reduce analyst upside and create selling pressure. RBC Cuts Price Target on Procter & Gamble to $167 UBS Lowers Procter & Gamble Price Target to $166 Piper Sandler Adjusts PT on Procter & Gamble to $142 Wells Fargo Adjusts PT on Procter & Gamble to $158
- Negative Sentiment: Analyst downgrade impact — Coverage notes the stock moved lower after recent downgrades, illustrating how sentiment shifts among major brokers are driving short‑term volatility. Procter & Gamble Stock Price Down 1.1% After Analyst Downgrade
About Procter & Gamble
Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
